<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610540</url>
  </required_header>
  <id_info>
    <org_study_id>FAB-1274</org_study_id>
    <nct_id>NCT05610540</nct_id>
  </id_info>
  <brief_title>Patient Preference and Visual Quality With Contralateral Synergy Versus Panoptix</brief_title>
  <official_title>Patient Preference and Visual Quality With Contralateral Synergy Versus Panoptix</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bucci Laser Vision Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bucci Laser Vision Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to compare the visual quality and patient preference of the Synergy&#xD;
      IOL versus the PanOptix IOL when one of each lens is placed in the same patient.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">November 2022</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Satisfaction - subjective questionnaire</measure>
    <time_frame>3 months to 18 months after cataract surgery</time_frame>
    <description>Subjective questionnaire explores the frequency and need for glasses for various visual functions at distance, intermediate, and near and overall satisfaction of visual function without glasses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity at Distance</measure>
    <time_frame>3 months to 18 months after cataract surgery</time_frame>
    <description>Uncorrected and best corrected visual acuities measured at distance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity at Intermediate</measure>
    <time_frame>3 months to 18 months after cataract surgery</time_frame>
    <description>Uncorrected and best corrected visual acuities measured at intermediate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity at Near</measure>
    <time_frame>3 months to 18 months after cataract surgery</time_frame>
    <description>Uncorrected and best corrected visual acuities measured at near</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>IOL</condition>
  <condition>Cataract</condition>
  <condition>Patient Satisfaction</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TECNIS Synergy IOL</intervention_name>
    <description>Implanted in one eye</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof PanOptix Trifocal IOL</intervention_name>
    <description>Implanted in one eye</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Males and females, aged 40 and older, with bilateral cataracts&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Bilateral cataracts for which phacoemulsification extraction and posterior IOL&#xD;
             implantation have been planned for both eyes&#xD;
&#xD;
          -  Desire to mitigate postoperative presbyopia with implantation of Synergy IOL in one&#xD;
             eye and PanOptix Trifocal IOL in the opposite eye&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any vision-limiting problems (e.g., corneal, retinal, infection) which can potentially&#xD;
             limit post-operative visual performance&#xD;
&#xD;
          -  Any ocular condition or trauma that is not resolved, stable, or would compromise the&#xD;
             well-being of the subject&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bucci Laser Vision Institute</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>October 31, 2022</study_first_submitted>
  <study_first_submitted_qc>November 3, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>November 3, 2022</last_update_submitted>
  <last_update_submitted_qc>November 3, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

